Array Keeps $1.4B-$1.5B Revenue Guidance, Raises EPS - Is the Selloff the Opportunity?

Array Beat Estimates, but the Stock Reaction Said the Market Still Wants Proof

Adjusted EPS of $0.24 versus $0.12 expected, with revenue of $342.1 million versus $317.9 million expected. Management also kept 2026 revenue guidance at $1.40 billion to $1.50 billion and raised EPS guidance to $0.68 to $0.75. On paper, that is a positive update.

Instead, Array traded down to $5.63 in regular trading before recovering to $5.76 after hours. The reaction suggests investors see a better-than-feared quarter, but not yet full confidence that full-year targets will hold.

That makes the next few reports more important than the day-one chart. If the stock can retain recent gains, investors may start treating the EPS raise as credible. If not, the market is still demanding harder proof.

What Drove Array's Second-Quarter Improvement

The quarter improved across several areas at once, not just in one accounting line.

Revenue, margins, and demand all moved higher

Revenue rose 53% sequentially to $342.1 million. Adjusted gross margin improved to 30.8%, and adjusted EBITDA margin reached 18.5%. Tracker shipments rose 38% sequentially, and management also pointed to stronger APA business activity.

The backlog remains a real visibility tool

Array posted a third straight record order book at $2.5 billion, added more than $500 million in quarterly bookings, and reported a 1.5x trailing book-to-bill ratio. Management also said the backlog is over 95% domestic and expects roughly 80% to convert over the next six quarters. If that conversion holds, the company has a clearer path into the second half of 2026 and into 2027.

Product mix is broadening

Products launched since 2023 now account for about half of the order book and nearly half of 2026 revenue. That does not guarantee margin strength, but it does suggest Array is becoming more than a one-product business.

The main risk is timing. Management warned that permitting, site readiness, and customer timing could push some revenue into 2027, and free-cash-flow conversion may land around 20% to 25% of adjusted EBITDA for the year.

The Market Is Still Evaluating Trust, Not Just the Latest Beat

Guidance history is why investors are cautious

Array has issued 21 guidance updates between August 9, 2022 and August 5, 2026, including 8 raises and 5 lowers. That history helps explain the market's skepticism: when guidance has changed often, investors tend to wait for execution before fully crediting an update.

Good numbers have not been enough by themselves

In the first quarter, Array reported EPS of $0.06 versus a consensus estimate of -$0.0547, a 209.69% positive surprise, yet the shares still declined 5.42%. The same pattern showed up again after the second quarter: even after adjusted EPS of $0.24 and revenue of $342.1 million beat expectations, the stock fell 6.32% in regular trading to $5.63 and only partially recovered after hours.

That pattern points to a simple issue: investors want proof that the improvement is durable, not just that the latest quarter came in ahead of estimates.

What Would Turn This Selloff Into an Opportunity

Q3 revenue guidance is the first clear test

Management's Q3 revenue guidance of $310 million to $330 million is the nearest checkpoint. If Array meets or beats that range, investors have a stronger case for treating backlog conversion as workable. If it misses, the market's hesitation is likely to deepen.

Margin durability matters as the year progresses

The company has warned that timing delays could shift some revenue into 2027 and pressure the back-half mix. The key question is whether the better product mix and broader platform adoption are enough to offset that pressure.

Cash conversion is the real credibility test

Management expects free-cash-flow conversion of about 20% to 25% of adjusted EBITDA for the year. If cash follows the backlog, the selloff becomes easier to view as an opportunity. If project slippage pushes revenue and cash further out, the market's trust discount is likely to persist.

The next few quarters will decide the story

The most important proof points are straightforward: - Q3 revenue comes in at or above the $310 million-$330 million range. - Backlog conversion stays on schedule. - Margins hold up enough to support the raised EPS range. - Free-cash-flow conversion remains near the 20%-25% target.

If those checks hold, the market may start rewarding the operating improvement. If they do not, the stock's caution is likely to remain justified.